COLL Q2 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4M

Gross Profit

$3M83.8% margin

Operating Income

-$21M-597.1% margin

Net Income

-$21M-593.3% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

+63.9%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$125M

Total Liabilities

$29M

Stockholders' Equity

$96M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$21M	-$24M	+13.1%
Net Income	-$21M	-$25M	+13.9%